CIC
GMED icon

Chase Investment Counsel’s Globus Medical GMED Stock Holding History

Chase Investment Counsel’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,350
Closed -$525K – 135
2024
Q4 		$525K Buy
+6,350
New +$501K 0.17% 89

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chase Investment Counsel's GMED Position: Q1 2025 in Review

Chase Investment Counsel sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 6,350 shares — an estimated $525K sold.

Chase Investment Counsel first reported a position in GMED in Q4 2024 and held it in 1 quarter. The position peaked at $525K in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • Chase Investment Counsel reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
  • Chase Investment Counsel sold 6,350 Globus Medical shares in Q1 2025, an estimated $525K.
  • Chase Investment Counsel first reported a position in Globus Medical in Q4 2024 and held it in 1 quarter.
  • Chase Investment Counsel's Globus Medical position peaked at $525K in Q4 2024.
  • 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Chase Investment Counsel's 13F filing for Q1 2025, filed 12 May 2025.